← FDA Drug Approvals (Drugs@FDA)

FUROSCIX

NDA · New Drug Application · Sponsor: SCPHARMACEUTICALS · Approved 2022-10-07

Drug application

FDA Application #
NDA209988
Application type
New Drug Application
Brand name
FUROSCIX
Generic name
FUROSEMIDE INJECTION 80 MG/ 10 ML
Active ingredients
FUROSEMIDE
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Marketing status
Prescription
Sponsor
SCPHARMACEUTICALS
Manufacturer
scPharmaceuticals Inc.
First approval
2022-10-07

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown